DOPPL SA is a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We engage in partnered projects for preclinical drug development by providing relevant, high-quality, and scalable organoid models.
| Website | http://www.doppl.ch |
| Employees | 14 (10 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Organoids, Disease Modeling, Personalized Medicine, Preclinical Drug Development, Drug Discovery, Biotechnology, Tissue Engineering, Regenerative Medicine, Pharmaceutical Research, Biomedical Research, Cell Based Assays, In Vitro Models, High Throughput Screening, Drug Screening, Toxicology Testing, Biopharma, Life Sciences, Clinical Trials, Therapeutics |
| Competitors | LoungeUp, Guestline DACH, Revinate, Zingle, Checkmate.io, TrustYou, RoomRaccoon Hotel Tech, Hotelogix, MEWS SYSTEMS LIMITED +36 more (view full list) |
Looking for a particular Doppl SA employee's phone or email?
Sylke Hoehnel-Ka is the Founder, Board Member and CEO of Doppl SA.
10 people are employed at Doppl SA.